1-11 of 11
Amrita Krishnan, M.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cause-Specific Conditional Survival In 2603 Consecutive Patients Undergoing Autologous Hematopoietic Cell Transplantation (aHCT) Over a 20-Year Period

Ari M. Vander Walde, M.D., M.P.H., Can-Lan Sun, Ph.D., Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Neal Kogut, M.D., Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia
Journal: Blood
Blood (2010) 116 (21): 933.
https://doi.org/10.1182/blood.V116.21.933.933
Published: 2010
Journal Articles

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

Lester A. Laddaran, B.A., Can-Lan Sun, Ph.D., Ari M. VanderWalde, MD, MPH, Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Chatchada Karanes, MD, Neil Martin Kogut, MD, Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Margaret O'Donnell, M.D., F.R.C.P.C., Pablo Parker, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia
Journal: Blood
Blood (2010) 116 (21): 902.
https://doi.org/10.1182/blood.V116.21.902.902
Published: 2010
Journal Articles

Tandem Autologous Hematopoietic Stem Cell Transplants (AuHCT) with or without Maintenance Therapy (auto-auto) Versus Single AuHCT Followed by HLA Matched Sibling Non- Myeloablative Allogeneic HCT (auto-allo) for Patients with Standard Risk (SR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial

Amrita Krishnan, M.D., Marcelo C Pasquini, MD, MS, Marian Ewell, ScD, Edward A. Stadtmauer, MD, Edwin P Alyea, III, MD, Joseph H. Antin, MD, Raymond L. Comenzo, MD, Stacey Goodman, MD, Parameswaran Hari, MD, Robert Negrin, MD, Muzaffar H. Qazilbash, MD, Scott D Rowley, Firoozeh Sahebi, George Somlo, MD, David H. Vesole, MD, PhD, Dan T. Vogl, MD, MSCE, Daniel J. Weisdorf, MD, Nancy Geller, PhD, Mary M. Horowitz, MD, MS, Sergio Giralt, MD, David G. Maloney
Journal: Blood
Blood (2010) 116 (21): 41.
https://doi.org/10.1182/blood.V116.21.41.41
Published: 2010
Journal Articles

Comparative Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy (RIT) Based Conditioning Versus Total Body Irradiation (TBI) for High-Risk Diffuse Large Cell Lymphoma (DLCL): Toxicity and Efficacy

Amrita Krishnan, M.D., Joycelynne Palmer, PhD, Auayporn Nademanee, M.D., Andrew Raubitschek, MD, Dave Yamauchi, Neil Martin Kogut, MD, Laura Federico, Nicole Tsai, Stephen Forman, M.D.
Journal: Blood
Blood (2010) 116 (21): 32.
https://doi.org/10.1182/blood.V116.21.32.32
Published: 2010
Journal Articles

Meta-Analysis of Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) with Comparison to a Historical Control (HC).

Paul G Richardson, Gideon Steinbach, M.D., Nancy Kernan, M.D., Eva C. Guinan, MD, Allen R. Chen, MD, PhD, MHS, Paul L Martin, MD, PhD, Amrita Krishnan, M.D., Sally Arai, MD, Joel A. Brochstein, MD, Stephan A. Grupp, M.D., Ph.D., Shin Mineishi, M.D., Amanda Termuhlen, MD, Marcie Tomblyn, MD, MS, Joseph H. Antin, MD, Carolyn Revta, Robin Hume, M.S., Joseph Massaro, Ph.D., Alison L. Hannah, MD, Massimo Iacobelli, MD, Robert J Soiffer, MD, Defibrotide Study Group
Journal: Blood
Blood (2010) 116 (21): 3481.
https://doi.org/10.1182/blood.V116.21.3481.3481
Published: 2010
Journal Articles

Tandem Autologous Stem Cell Transplants (auto-auto) with or without Maintenance Therapy Versus Single Autologous Transplant Followed by HLA-Matched Sibling Non- Myeloablative Allogeneic Stem Cell Transplant (auto-allo) for Patients (pts) with High Risk (HR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0102 Trial

Edward A Stadtmauer, MD, Amrita Krishnan, M.D., Marcelo C Pasquini, MD, MS, Marian Ewell, ScD, Edwin P Alyea, III, MD, Joseph H. Antin, MD, Hugo Castro-Malaspina, MD, Adetola A. Kassim, MD, MS, Robert Negrin, MD, Muzaffar H. Qazilbash, MD, J. Douglas Rizzo, MD, MS, Scott D Rowley, Firoozeh Sahebi, George Somlo, MD, David H. Vesole, MD, PhD, Dan T. Vogl, MD, MSCE, Daniel J. Weisdorf, MD, Nancy Geller, PhD, Mary M. Horowitz, MD, MS, David G. Maloney, Sergio Giralt, MD
Journal: Blood
Blood (2010) 116 (21): 526.
https://doi.org/10.1182/blood.V116.21.526.526
Published: 2010
Journal Articles

Analysis of Risk Factors and Outcome for Extramedullary Relapses Post Allogeneic Stem Cell Transplantation for Myeloma.

Myo Htut, MD, Firoozeh Sahebi, M.D., George Somlo, MD, Pablo Parker, M.D., Chatchada Karanes, MD, Andy Dagis, Susan Hmwe, Tanya Paris, Joyce Murata-Collins, PhD, Leslie Popplewell, M.D., Joycelynne Palmer, PhD., Stephen Forman, M.D., Amrita Krishnan, M.D.
Journal: Blood
Blood (2010) 116 (21): 4562.
https://doi.org/10.1182/blood.V116.21.4562.4562
Published: 2010
Journal Articles

High Rate of Complete Remission (CR) and Upgraded Response with Weekly Maintenance Bortezomib Post Single Autologous Peripheral Stem Cell Transplant (PSCT) In Patients with Multiple Myeloma. Results of a Phase II Prospective Study

Firoozeh Sahebi, M.D., Amrita Krishnan, M.D., Leonardo Farol, MD, Ji-Lian Cai, MD, George Somlo, MD, Leslie Popplewell, M.D., R. Spielberger, M.D., Neil Martin Kogut, MD, Chatchada Karanes, MD, Christopher Ruel, Paul Frankel, Eunicia Reburiano, Margret O'Donnell, MD, Stephen Forman
Journal: Blood
Blood (2010) 116 (21): 2399.
https://doi.org/10.1182/blood.V116.21.2399.2399
Published: 2010
Journal Articles

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Sahebi Firoozeh, MD, Jeffery R. Schriber, M.D., Ricardo Spielberger, M.D., Ji-Lian Cai, M.D., Neil Martin Kogut, M.D., Peter M. Falk, M.D., Pablo Miguel Parker, M.D., Amrita Krishnan, M.D., Leslie Popplewell, M.D., Chatchada Karanes, M.D., Dajun Qian, PhD., Stephen J. Forman, M.D., George Somlo, M.D.
Journal: Blood
Blood (2007) 110 (11): 3030.
https://doi.org/10.1182/blood.V110.11.3030.3030
Published: 2007
Journal Articles

90 Y-Ibritumomab Tiuxetan (Zevalin®) in Combination with High-Dose Therapy (HDT) Followed by Autologous Stem Cell Transplant (ASCT) May Improve Survival in Patients with Poor-Risk Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Retrospective Comparative Analysis.

Auayporn P. Nademanee, MD, Amrita Krishnan, M.D, Nicole Tsai, MS, MPH, Joycelynne Palmer, Ph.D., Arturo Molina, M.D., Henry C. Fung, M.D., David Yamauchi, M.D, Neil Martin Kogut, M.D., Stephen J. Forman, M.D., Andrew Raubitschek, M.D.
Journal: Blood
Blood (2006) 108 (11): 327.
https://doi.org/10.1182/blood.V108.11.327.327
Published: 2006
Journal Articles

The Impact of Disease Status on the Outcome of High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT) for Peripheral T-Cell Lymphoma (PTCL).

Auayporn P. Nademanee, MD, Jasmine M. Zain, M.D., Joycelynne Palmer, Ph.D., Nicole Tsai, M.S., M.P.H., Neil Martin Kogut, M.D., Amrita Krishnan, M.D., Leslie Popplewell, M.D., Roberto Rodriguez, M.D., Eileen Patricia Smith, M.D., Stephen J. Forman, M.D.
Journal: Blood
Blood (2006) 108 (11): 3060.
https://doi.org/10.1182/blood.V108.11.3060.3060
Published: 2006